Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 42708-197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 42708-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 197 20 Label)

Label (42708 197 20 Label)
Label for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, 20 count, film-coated oral tablets by QPharma, Inc. The label includes placeholder text for dosage instructions, sample notice, storage at controlled room temperature, and indicates Rx only. NDC 42708-197-20 is shown.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride showing a tricyclic ring system with a side chain containing nitrogen and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.